Detsky AS, Naglie IG. A clinician’s guide to cost-effectiveness analysis [see comments]. Ann Intern Med. 1990;113(2):147-154.
2.
Tengs TO, Adams ME, Pliskin JS, et al.Five-hundred life-saving interventions and their cost-effectiveness [see comments]. Risk Anal. 1995;15(3):369-390.
3.
Ransohoff DF, Gracie WA, Wolfenson LB, Neuhauser D.Prophylactic cholecystectomy or expectant management for silent gallstones. A decision analysis to assess survival. Ann Intern Med. 1983;99(2):199-204.
4.
Molitch ME, Beck JR, Dreisman M, Gottlieb JE, Pauker SG. The cold thyroid nodule: an analysis of diagnostic and therapeutic options. Endocr Rev. 1984;5(2):185-199.
5.
Pauker SG. Coronary artery surgery: the use of decision analysis. Ann Intern Med. 1976;85(1):8-18.
Pauker SP, Pauker SG. The amniocentesis decision: ten years of decision analytic experience. Birth Defects Orig Arctic Ser. 1987;23(2):151-169.
8.
Pauker SG, Pauker SP. Prescriptive models to support decision making in genetics. Birth Defects Orig Arctic Ser. 1987;23(2):279-296.
9.
Tengs TO, Winer EP, Paddock S, Aguilar-Chavez O, Berry DA. Testing for the BRCA1 and BRCA2 breast-ovarian cancer susceptibility genes: a decision analysis. Med Decis Making. 1998;18(4):365-375.
10.
Tengs T, Berry D.The cost-effectiveness of testing for the BRCA1 and BRCA2 breast-ovarian cancer susceptibility genes. Med Decis Making. 1999;19:526.
11.
Stalmeier PF, Unic IJ, Verhoef LC, Van Daal WA. Evaluation of a shared decision making program for women suspected to have a genetic predisposition to breast cancer: preliminary results. Med Decis Making. 1999;19(3):230-241.
12.
Stalmeier P, Unic I, Verhoef L, van Daal W.Prophylactic mastectomy or screening: a study of women’s choices, medical and decision analytic recommendations. Med Decis Making. 1999;19:526.
13.
Dembitzer A, Sanders G, Goldstein M, Owens D.Cost-effectiveness of programs that screen for BRCA mutations in women. Med Decis Making. 1999;19:526.
14.
Barry MJ, Fowler FJ, JR., Mulley AG, JR., Henderson JV, JR., Wennberg JE. Patient reactions to a program designed to facilitate patient participation in treatment decisions for benign prostatic hyperplasia. Med Care. 1995;33(8):771-782.
15.
(A published erratum appears in Arch Intern Med. 1994;154(19):2254.)
16.
Laupacis A, Albers G, Dalen J, Dunn MI, Jacobson AK, Singer DE. Antithrombotic therapy in atrial fibrillation. Chest. 1998;114(5 Suppl):579S-589S.
17.
Thomson R, Parkin D, Eccles M, Sudlow M, Robinson A.Decision analysis and guidelines for anticoagulant therapy to prevent stroke in patients with atrial fibrillation. Lancet. 2000;355:956-962.
18.
Albers GW. Atrial fibrillation and stroke. Three new studies, three remaining questions. Arch Intern Med. 1994;154(13):1443-1448.
19.
Eckman MH, Pauker SG. Decision analytic issues in the management of atrial fibrillation. In: Falk RH, Podrid PJ, eds. Atrial Fibrillation: Mechanisms and Management. Philadelphia: Lippincott-Raven, 1997; p 469-488.
20.
Eckman MH, Levine HJ, Salem DN, Pauker SG. Making decisions about antithrombotic therapy in heart disease: decision analytic and cost-effectiveness issues. Chest. 1998;114(5 Suppl):699S-714S.
21.
Sanders GD, Hagerty CG, Sonnenberg FA, Hlatky MA, Owens DK. Distributed decision support using a Web-based interface: prevention of sudden cardiac death. Med Decis Making. 1999;19(2):157-166.
22.
Molenaar S, Sprangers MA, Postma-Schuit FC, et al.Feasibility and effects of decision aids. Med Decis Making. 2000;20(1):112-127.
23.
O’Connor AM, Rostom A, Fiset V, et al.Decision aids for patients facing health treatment or screening decisions: systematic review [see comments]. BMJ. 1999;319(7212):731-734.
24.
Bekker H, Thornton J, Airey C, et al.Informed decision making: an annotated bibliography and systematic review. Health Technol Assess. 1999;3(1):1-156.
25.
Kassirer JP, Pauker SG. The toss-up [editorial]. N Engl J Med. 1981;305(24):1467-1469.
